Delivery Order SPE2DB24D1205-SPE2DB25FCYBT
- Not listed
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 90-count tablets of Alfuzosin Hydrochloride Extended Release 10 milligram. The contract has a ceiling value of $2,202.21 and a period of performance through March 14, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 and...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $1,183.92 contract is for the supply of Alfuzosin Hydrochloride Extended Release (ER) 10 mg tablets. The order has a completion date of February 26, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,824.49 firm fixed-price contract is for the supply of Alfuzosin HCl ER 10 mg tablets. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which covers a comprehensive range of...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Alfuzosin HCl ER 10 mg tablets. The delivery order is valued at $2,592.98 and has a period of performance through May 8, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Alfuzosin HCL ER 10 mg tablets in 90-count quantities. The contract has a ceiling value of $1,394.27 and a completion date of May 22, 2025. It is a firm-fixed-price delivery order contract, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $5,634.00 firm-fixed-price delivery order is for the supply of Alfuzosin Hydrochloride Extended-Release 10 mg Tablets in 120-count packages. The contract has an ultimate completion date of August 23, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 120 tablets of Alfuzosin Hydrochloride Extended Release 10 mg, a medication used to treat an enlarged prostate. The contract has a firm fixed price of $2,107.38 and a completion date of May 28, 2025. This delivery order is not set aside and was awarded on May 27, 2025....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,193.95 firm-fixed-price delivery order is for the supply of 90-count bottles of the prescription medication Alfuzosin HCl Extended-Release 10 mg Tablets. The contract has an ultimate completion date of May 14, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,259,183 units of the prescription medication alfuzosin hydrochloride extended-release 10 mg tablets. The contract, valued at $1,368.25, is a firm-fixed price delivery order awarded on July 26, 2024, with a completion date of July 29, 2024. This contract is not associated with a set-aside...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,173.75 firm fixed-price contract is for the delivery of 120 tablets of Alfuzosin Hydrochloride Extended-Release 10 mg, a medication used to treat benign prostatic hyperplasia. The contract has a completion date of February 15, 2024 and was awarded on February 14, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCYBTDelivery Order
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,710.09, is for the delivery of alfuzosin hydrochloride extended-release 10 milligram tablets in 90-count packages. The contract is a firm-fixed-price delivery order with a completion date of June 27, 2025. This award is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is part of the company's broader role as a critical vendor supporting federal medical procurement needs, particularly for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 6/26/25 |